Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients: A Novel Application of Direct-Acting Antiviral Drugs
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 26 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated
- 06 Jun 2018 Planned number of patients changed from 10 to 25.